Cross-species immunity in malaria vaccine development: Two, three, or even four for the price of one?

Infection and Immunity

Volumn 76, Issue 3, 2008, Pages 873-878

  Douradinha, Bruno ^a,d   Mota, Maria M ^b,c   Luty, Adrian J F ^a   Sauerwein, Robert W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LISBON   (Portugal)

^c INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^d NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MALARIA VACCINE;

ANTIBODY RESPONSE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CROSS REACTION; HUMAN; IMMUNITY; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VINCKEI; PLASMODIUM VIVAX; PLASMODIUM YOELII; PRIORITY JOURNAL; SHORT SURVEY; SPOROZOITE; ANIMAL; IMMUNOLOGY; PLASMODIUM; REVIEW;

ANIMALS; CROSS REACTIONS; HUMANS; MALARIA VACCINES; PLASMODIUM;

EID: 40749153135     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00431-07     Document Type: Short Survey

References (77)

1. Amino, R., S. Thiberge, B. Martin, S. Celli, S. Shorte, F. Frischknecht, and R. Ménard. 2006. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat. Med. 12:220-224.
2. Belnoue, E., F. T. Costa, T. Frankenberg, A. M. Vigário, T. Voza, N. Leroy, M. M. Rodrigues, I. Landau, G. Snonnou, and L. Rénia. 2004. Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 172:2487-2495.
3. + T cells. J. Immunol. 171:2024-2034.
4. Boyd, M., and S. F. Kitchen. 1937. Recurring clinical activity in infections with the McCoy strain of Plasmodium vivax. Am. J. Trop. Med. 17:833-843.
5. Boyd, M., and S. F. Kitchen. 1937. Simultaneous inoculation with Plasmodium vivax and Plasmodium falciparum. Am. J. Trop. Med. 17:855-861.
6. Boyd, M., and S. F. Kitchen. 1938. Vernal vivax activity in persons simultaneously inoculated with Plasmodium vivax and Plasmodium falciparum. Am. J. Trop. Med. 18:505-514.
7. Bruce, M. C., and K. P. Day. 2003. Cross-species regulation of Plasmodium parasitemia in semi-immune children from Papua New Guinea. Trends Parasitol. 19:271-277.
8. Bruce-Chwatt, L. 1963. A longitudinal survey of natural malaria infection in a group of West African adults. West Afr. Med. J. 12:199-217.
9. Butcher, G. 1998. Cross-species immunity in malaria. Parasitol. Today 14: 166.
10. Butcher, G. A., and I. A. Clark. 1990. The inhibition of Plasmodium falciparum growth in vitro by sera from mice infected with malaria or treated with TNF. Parasitology 101:321-326.
11. Ciuca, M., A. Soflete, E. Teriteanu, P. Constantinescu, and P. Cortez. 1953. Effect of combined chloroquine and plasmocid therapy on various Plasmodium species inoculated for therapeutic purposes. Bul. Stiint. Sect. Stiinte Med. Acad. Repub. Pop. Romane 5:381-392.
12. Clyde, D. F., H. Most, V. C. McCarthy, and J. Vanderberg. 1973. Immunization of man against sporozoite-induced falciparum malaria. Am. J. Med. Sci. 266:398-403.
13. Cochrane, A. H., W. E. Collins, and R. S. Nussenzweig. 1984. Monoclonal antibody identifies circumsporozoite protein of Plasmodium malariae and detects a common epitope on Plasmodium brasilianum sporozoites. Infect. Immun. 45:592-595.
14. Collins, W. E., and P. G. Contacos. 1972. Immunization of monkeys against Plasmodium cynomolgi by X-irradiated sporozoites. Nat. New Biol. 236:176-177.
15. Collins, W. E., and G. M. Jeffery. 1999. A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity. Am. J. Trop. Med. Hyg. 61:36-43.
16. Cox, F. E. 1970. Protective immunity between malaria parasites and piroplasms in mice. Bull. W. H. O. 43:325-336.
17. Doolan, D. L., and S. L. Hoffman. 2000. The complexity of protective immunity against liver stage malaria. J. Immunol. 165:1453-1462.
18. + T cells in the Plasmodium yoelii model. J. Immunol. 2:884-892.
19. Douradinba, B., M. R. van Dijk, R. Ataide, G.-J. van Gemert, J. Thompson, J.-F. Franetich, D. Mazier, A. J. F. Luty, R. Sauerwein, C. J. Janse, A. P. Waters, and M. M. Mota. 2007. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting and partial cross-species protection. Int. J. for Parasitol. 37:1511-1519.
20. Escalante, A., and F. Ayala. 1994. Phylogeny of the malarial genus Plasmodium, derived from rRNA gene sequences. Proc. Natl. Acad. Sci. USA 91:11373-11377.
21. Franke, E. D., S. L. Hoffman, J. B. Sacci, Jr., R. Wang, Y. Charoenvit, E. Appella, R. Chesnut, J. Alexander, M.-F. del Guercio, and A. Sette. 1999. Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites. Vaccine 17:1201-1205.
22. Gunewardena, D. M., R. Carter, and K. N. Mendis. 1994. Patterns of acquired anti-malarial immunity in Sri Lanka. Mem. Inst. Oswaldo Cruz 89: 63-65.
23. Hall, N., M. Karras, J. D. Raine, J. M. Carlton, T. W. A. Kooij, M. Berriman, L. Florens, C. S. Janssen, A. Pain, G. K. Christophides, K. James, K. Rutherford, B. Harris, D. Harris, C. Churcher, M. A. Quail, D. Ormond, J. Doggett, H. E. Trueman, J. Mendoza, S. L. Bidwell, M.-A. Rajandream, D. J. Carucci, J. R. Yates III, F. C. Kafatos, C. J. Janse, B. Barrell, C. M. R. Turner, A. P. Waters, and R. E. Sinden. 2005. A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 307:82-86.
24. Hill, A. V. 2006. Pre-erythrocytic malaria vaccines: towards greater efficacy. Nat. Rev. Immunol. 6:21-32.
25. Hoffman, S. L., L. M. Goh, T. C. Luke, I. Schneider, T. P. Le, D. L. Doolan, J. Sacci, P. de la Vega, M. Dowler, C. Paul, D. M. Gordon, J. A. Stoute, L. W. Church, M. Sedegah, D. G. Heppner, W. R. Ballou, and T. L. Richie. 2002. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185:1155-1164.
26. Jarra, W., and K. N. Brown. 1985. Protective immunity to malaria: studies with cloned lines of Plasmodium chabaudi and P. berghei in CBA/Ca mice. I. The effectiveness and inter- and intra-species specificity of immunity induced by infection. Parasite Immunol. 7:595-606.
27. Jeffery, G. M. 1966. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmodium. Bull. W. H. O. 35:873-882.
28. Kaiser, K., K. Matuschewski, N. Camargo, J. Ross, and S. H. Kappe. 2004. Differential transcriptome profiling identifies Plasmodium genes encoding pre-erythrocytic stage-specific proteins. Mol. Microbiol. 55:1221-1232.
29. Krzyeh, U., R. Schwenk, M. Guebre-Xabier, P. Sun, D. Palmer, K. White, and I. Chalom. 2000. The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites. Immunol. Rev. 174:123-134.
30. Kumar, N., J. Perez Folgar, and P. Lubega. 1992. Recognition of Plasmodium falciparum asexual stage antigens by antibodies in sera from people exposed to Plasmodium vivax. Am. J. Trop. Med. Hyg. 47:422-428.
31. Labaied, M., A. Harupa, R. F. Dumpit, I. Coppens, S. A. Mikolajczak, and S. H. I. Kappe. 2007. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Infect. Immun. 75:3758-3768.
32. Lee, M., and C. Lambros. 1988. The Elisa-U: an enzyme-linked immunosorbent assay using urease as the enzyme marker for rapid detection of Plasmodium falciparum antibody in human serum. Am. J. Trop. Med. Hyg. 39:421-426.
33. Legorreta-Herrera, M., M. L. Ventura-Ayala, R. N. Licona-Chavez, I. Soto-Cruz, and F. F. Hernandez-Clemente. 2004. Early treatment during a primary malaria infection modifies the development of cross immunity. Parasite Immunol. 26:7-17.
34. Leirião, P., S. S. Albuquerque, S. Corso, G. J. van Gemert, R. W. Sauerwein, A. Rodriguez, S. Giordana, and M. M. Mota. 2005. HGF/MET signalling protects Plasmodium-infected host cells from apoptosis. Cell. Microbiol. 7:603-609.
35. Leirião, P., M. M. Mota, and A. Rodriguez. 2005. Apoptotic Plasmodium-infected hepatocytes provide antigens to liver dendritic cells. J. Infect. Dis. 191:1576-1581.
36. Luke, T. C., and S. L. Hoffman. 2003. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J. Exp. Biol. 206:3803-3808.
37. Maitland, K., T. N. Williams, S. Bennett, C. I. Newbold, T. E. Peto, J. Viji, R. Timothy, J. B. Clegg, D. J. Weaterall, and D. K. Bowden. 1996. The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo Island, Vanuatu. Trans. R. Soc. Trop. Med. Hyg. 90:614-620.
38. Maitland, K., T. N. Williams, and C. I. Newbold. 1997. Plasmodium vivax and P. falciparum: biological interactions and the possibility of cross-species immunity. Parasitol. Today 13:227-231.
39. Maitland, K., T. N. Williams, T. E. Peto, K. P. Day, J. B. Clegg, D. J. Weaterall, and D. K. Bowden. 1997. Absence of malaria-specific mortality in children in an area of hyperendemic malaria. Trans. R. Soc. Trop. Med. Hyg. 91:562-566.
40. Matuschewski, K., J. Ross, S. M. Brown, K. Kaiser, V. Nussenzweig, and S. H. Kappe. 2002. Infectivity-associated changes in the transcriptional repertoire of the malaria parasite sporozoite stage. J. Biol. Chem. 277:41948-41953.
41. McColm, A. A., and L. Dalton. 1983. Heterologous immunity in rodent malaria: comparison of the degree of cross-immunity generated by vaccination with that produced by exposure to live infection. Ann. Trop. Med. Parasitol. 77:355-377.
42. Michon, P., J. L. Cole-Tobian, E. Dabod, S. Schoepflin, J. Igu, M. Susapu, N. Tarongka, P. A. Zimmerman, J. C. Reeder, J. G. Beeson, L. Schofield, C. L. King, and I. V. O. Mueller. 2007. The risk of malarial infections and disease in Papua New Guinean children. Am. J. Trop. Med. Hyg. 76:997-1008.
43. Moorthy, V. S., M. F. Good, and A. V. Hill. 2004. Malaria vaccine developments. Lancet 363:150-156.
44. Mota, M. M., J. C. Hafalla, and A. Rodriguez. 2002. Migration through host cells activates Plasmodium sporozoites for infection. Nat. Med. 8:1318-1322.
45. Mota, M. M., G. Pradel, J. P. Vanderberg, J. C. R. Hafalla, U. Frevert, R. S. Nussenzweig, V. Nussenzweig, and A. Rodriguez. 2001. Migration of Plasmodium sporozoites through cells before infection. Science 291:141-144.
46. Mueller, A. K., M. Labaied, S. H. Kappe, and K. Matuschewski. 2005. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433:164-167.
47. Mueller, A. K., N. Camargo, K. Kaiser, C. Andorfer, U. Frevert, K. Matuschewski, and S. H. Kappe. 2005. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc. Natl. Acad. Sci. USA 102:3022-3027.
48. Mueller, A. K., M. Deckert, K. Heiss, K. Goetz, K. Matuschewski, and D. Schlüter. 2007. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells. Am. J. Pathol 171:107-115.
49. Nabel, G. 2004. Genetic, cellular and immune approaches to disease therapy: past and future. Nat. Med. 10:135-141.
50. Nussenzweig, R. S., J. Vanderberg, H. Most, and C. Orton. 1967. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216:160-162.
51. Nussenzweig, R. S., J. P. Vanderberg, H. Most, and C. Orton. 1969. Specificity of protective immunity produced by X-irradiated Plasmodium berghei sporozoites. Nature 222:488-489.
52. Nussenzweig, R. S., J. Vanderberg, G. L. Spitalny, C. I. O. Rivera, C. Orton, and H. Most. 1972. Sporozoite-induced immunity in mammalian malaria. A review. Am. J. Trop. Med. Hyg. 21:722-728.
53. Perkins, S., I. Sarkar, and R. Carter. 2007. The phylogeny of rodent malaria parasites: simultaneous analysis across three genomes. Infect. Genet. Evol 7:74-83.
54. Pizza, M., A. Covacci, A. Bartoloni, M. Perugini, L. Nencioni, M. T. De Magistris, L. Villa, D. Nncci, R. Manetti, M. Bugnoli, et al. 1989. Mutants of pertussis toxin suitable for vaccine development. Science 246:497-500.
55. Redmond, W. B. 1939. The cross-immune relationship of various strains of Plasmodium cathemerium and P. relictum. J. Infect. Dis. 64:273-287.
56. + T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150:1471-1478.
57. Rénia, L., A. C. Gruner, M. Mauduit, and G. Snounou. 2006. Vaccination against malaria with live parasites. Exp. Rev. Vaccines. 5:473-481.
58. + T lymphocytes from mice immunized with a synthetic malaria peptide. Proc. Natl. Acad. Sci. USA 88:7963-7967.
59. Richie, T. L. 1988. Interactions between malaria parasites infecting the same vertebrate host. Parasitology 96:607-639.
60. Romero, P., J. L. Maryanski, G. Corradin, R. S. Nussenzweig, V. Nussenzweig, and F. Zavala. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323-326.
61. Sacci, J. B., Jr., M. E. Schriefer, J. H. Resau, R. A. Wirtz, L. J. Detolla, Jr., R. B. Markham, and A. F. Azad. 1992. Mouse model for exoerythrocytic stages of Plasmodium falciparum malaria parasite. Proc. Natl. Acad. Sci. USA 89:3701-3705.
62. Sattabongkot, J., N. Yimamnuaychoke, S. Leelaudomlipi, M. Rasameesoraj, R. Jenwithisuk, R. E. Coleman, R. Udomsangpetch, L. Cui, and T. G. Brewer. 2006. Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am. J. Trop. Med. Hyg. 74:708-715.
63. Schofield, L., J. Villaquiran, A. Ferreira, H. Schellekens, R. Nussenzweig, and V. Nussenzweig. 1987. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664-666.
64. Sherman, I. W. 1998. Malaria: parasite biology, pathogenesis, and protection. American Society for Microbiology Press, Washington, DC.
65. Sina, B. J., V. E. do Rosário, G. Woollett, K. Sakhuja, and M. R. Hollindale. 1993. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection. Exp. Parasitol. 77:129-135.
66. Smith, T., B. Genton, K. Baea, N. Gibson, A. Narara, and M. P. Alpers. 2001. Prospective risk of morbidity in relation to malaria infection in an area of high endemicity of multiple species of Plasmodium. Am. J. Trop. Med. Hyg. 64:262-267.
67. Suhrbier, A., L. A. Winger, E. Castellano, and R. E. Sinden. 1990. Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells. Infect. Immun. 58:2834-2839.
68. Taliaferro, W. H. 1939. Immunity to the malaria infections, p. 941-942. In M. Boyd (ed.), Malariology. W. B. Saunders & Co., Philadelphia, PA.
69. Thompson, J., C. J. Janse, and A. P. Waters. 2001. Comparative genomics in Plasmodium: a tool for the identification of genes and functional analysis. Mol. Biochem. Parasitol. 118:147-154.
70. Vanderberg, J. P., R. S. Nussenzweig, H. Most, and C. G. Orton. 1968. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. II. Effects of radiation on sporozoites. J. Parasitol. 54:1175-1180.
71. van de Sand, C., S. Horstmann, A. Schmidt, A. Sturm, S. Bolte, A. Krueger, M. Lutgehetmann, J. M. Pollok, C. Libert, and V. T. Volker. 2005. The liver stage of Plasmodium berghei inhibits host cell apoptosis. Mol. Microbiol. 58:731-742.
72. van Dijk, M. R., B. Douradinha, B. Franke-Fayard, V. Heussler, M. W. van Dooren, B. van Schaijk, G. J. van Gemert, R. W. Sauerwein, M. M. Mota, A. P. Waters, and C. J. Janse. 2005. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc. Natl. Acad. Sci. USA 102:12194-12199.
73. Voza, T., A. M. Vigário, E. Belnoue, A. C. Gruner, J. C. Deschemin, M. Kayibanda, F. Delmas, C. J. Janse, B. Franke-Fayard, A. P. Waters, I. Landau, G. Snounou, and L. Rénia. 2005. Species-specific inhibition of cerebral malaria in mice coinfected with Plasmodium spp. Infect. Immun. 73:4777-4786.
74. Weger, C. 1999. Another Tuskegee? Am. J. Trop. Med. Hyg. 61:1-3.
75. Weiss, W. R., J. A. Berzofsky, R. A. Houghten, M. Sedegah, M. Hollindale, and S. L. Hoffman. 1992. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei. J. Immunol. 149:2103-2109.
76. Winau, F., S. H. Kaufmann, and U. E. Schaible. 2004. Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria. Cell. Microbiol. 6:599-607.
77. Xu, L., X. Pei, K. Berzins, and A. Chaudhuri. 2007. Plasmodium yoelii: experimental evidences for the conserved epitopes between mouse and human malaria parasite, Plasmodium falciparum. Exp. Parasitol. 116:214-224.